Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC1A1 | P43005 | 2/20 | 0.38 |
| ▸ | GRM8 | O00222 | 1/20 | 0.38 |
| ▸ | GRM6 | O15303 | 1/20 | 0.38 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.38 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.38 |
| ▸ | GSR | P00390 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.38 |
| ▸ | GRM5 | P41594 | 1/20 | 0.38 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.38 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.38 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.38 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.38 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.38 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.38 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.38 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.38 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.38 |
| ▸ | GRIK3 | Q13003 | 1/20 | 0.38 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL648219 | 1.00 | SLC1A1 (0.38) | SLC1A1GRM8GRM6GRIN2DGRIN3B | |
| SCHEMBL3510151 | 1.00 | SLC1A1 (0.38) | SLC1A1GRM8GRM6GRIN2DGRIN3B | |
| SCHEMBL21002223 | 0.87 | GSR (0.33) | SLC1A1GRM8GRM6GRIN2DGRIN3B | |
| SCHEMBL2723398 | 0.85 | SLC1A1 (0.51) | SLC1A1GRM8GRM6GRIN2DGRIN3B | |
| SCHEMBL29831114 | 0.82 | GRM8 (0.60) | SLC1A1GRM8GRM6GRIN2DGRIN3B | |
| SCHEMBL22502695 | 0.82 | GRM8 (0.60) | SLC1A1GRM8GRM6GRIN2DGRIN3B | |
| SCHEMBL5496875 | 0.82 | GRM8 (0.60) | SLC1A1GRM8GRM6GRIN2DGRIN3B | |
| SCHEMBL167845 | 0.82 | ALOX15 (0.58) | SLC1A1GRM8GRM6GRIN2DGRIN3B | |
| SCHEMBL8697 | 0.82 | SLC1A1 (0.60) | SLC1A1GRM8GRM6GRIN2DGRIN3B | |
| SCHEMBL17724321 | 0.82 | SLC1A1 (0.60) | SLC1A1GRM8GRM6GRIN2DGRIN3B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 68 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200270202-A1 | POTENT INHIBITORS OF ASPARTATE N-ACETYL-TRANSFERASE FOR THE TREATMENT OF CANAVAN DISEASE | THE UNIVERSITY OF TOLEDO (US) | 2020-08-27 | — | — | US | claimed |
| WO-2017172476-A1 | POTENT INHIBITORS OF ASPARTATE N-ACETYL-TRANSFERASE FOR THE TREATMENT OF CANAVAN DISEASE | THE UNIVERSITY OF TOLEDO (US) | 2017-10-05 | — | — | WO | claimed |
| EP-2661493-B1 | PLASMINOGEN AND PLASMIN VARIANTS | THROMBOGENICS NV (BE) | 2016-03-30 | — | — | EP | claimed |
| EP-2661493-A1 | PLASMINOGEN AND PLASMIN VARIANTS | ThromboGenics N.V. (BE) | 2013-11-13 | — | — | EP | claimed |
| US-20130273028-A1 | PLASMINOGEN AND PLASMIN VARIANTS | THROMBOGENICS NV (BE) | 2013-10-17 | — | — | US | claimed |
| WO-2012093132-A1 | PLASMINOGEN AND PLASMIN VARIANTS | THROMBOGENICS NV (BE) | 2012-07-12 | — | — | WO | claimed |
| US-20060058221-A1 | Baclofen conjugate and a pharmaceutical composition for treatment of neuronal disorders | MILLER LANDON C | 2006-03-16 | — | — | US | claimed |
| WO-2024118297-A1 | BIOPROSTHETIC TISSUE AND PROSTHETIC ANTIMICROBIAL TREATMENT | EDWARDS LIFESCIENCES CORPORATION (US) | 2024-06-06 | — | — | WO | disclosed |
| US-20230240966-A1 | COMPOSITIONS AND METHODS FOR TREATING HAIR FOLLICLE-LINKED CONDITIONS | HENLEZ APS (DK) | 2023-08-03 | — | — | US | disclosed |
| EP-4171237-A1 | USE OF AN ORGANO-MINERAL COMPOSITION VIA FOLIAR APPLICATION TO STIMULATE PLANT DEVELOPMENT IN THE PRESENCE OF AT LEAST ONE ABIOTIC STRESS OR BIOTIC STRESS | Olmix (FR) | 2023-05-03 | — | — | EP | disclosed |
| US-20230104647-A1 | METHODS AND PROCESSES FOR THE PREPARATION OF KDM1A INHIBITORS | IMAGO BIOSCIENCES, INC. | 2023-04-06 | — | — | US | disclosed |
| CN-111182911-B | Composition for protecting retinal nerve cells comprising processed product of cowberry fruit and processed product of pine bark | 参天制药株式会社 | 2023-04-04 | — | — | CN | disclosed |
| EP-4135755-A1 | COMPOSITIONS AND METHODS FOR TREATING HAIR FOLLICLE-LINKED CONDITIONS | Henlez ApS (DK) | 2023-02-22 | — | — | EP | disclosed |
| WO-2005004897-A1 | WATER-SOLUBLE SHPS AS NOVEL ALKYLATING AGENTS | VION PHARMACEUTICALS, INC. (US) | 2005-01-20 | — | — | WO | disclosed |
| US-20040254103-A1 | WATER-SOLUBLE SHPS AS NOVEL ALKYLATING AGENTS | NANOSHIFT, LLC | 2004-12-16 | — | — | US | disclosed |
| US-20020169125-A1 | Fusion protein such as of polyglutamic acid and interferon-alpha; improves bioactivity and water-solubility properties of a drug to which it is conjugated | CELL THERAPEUTICS, INC. | 2002-11-14 | — | — | US | disclosed |
| WO-2002077036-A2 | RECOMBINANT PRODUCTION OF POLYANIONIC POLYMERS, AND USES THEREOF | CELL THERAPEUTICS, INC. (US) | 2002-10-03 | — | — | WO | disclosed |
| US-6444644-B1 | PEPTIDE HAVING SPECIFIED AMINO ACID SEQUENCE; USED FOR INHIBITION OF THROMBOPLASTIN | UNIVERSITY COLLEGE LONDON (GB) | 2002-09-03 | — | — | US | disclosed |
| EP-0917539-A1 | ANTICOAGULANT PEPTIDE FRAGMENTS DERIVED FROM APOLIPOPROTEIN B-100 | UNIVERSITY COLLEGE LONDON (GB) | 1999-05-26 | — | — | EP | disclosed |
| WO-1997043311-A1 | ANTICOAGULANT PEPTIDE FRAGMENTS DERIVED FROM APOLIPOPROTEIN B-100 | UNIVERSITY COLLEGE LONDON (GB) | 1997-11-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230104647-A1 | METHODS AND PROCESSES FOR THE PREPARATION OF KDM1A INHIBITORS | KDM1A, KDM1B, KDM2A | SLC1A1 3968/4885GRM8 3103/4885GRM6 3535/4885 |
| US-20200270202-A1 | POTENT INHIBITORS OF ASPARTATE N-ACETYL-TRANSFERASE FOR THE TREATMENT OF CANAVAN DISEASE | GOT1, ACAT1, GOT2 | SLC1A1 268/4885GRM8 4111/4885GRM6 3615/4885 |
| US-20040254103-A1 | WATER-SOLUBLE SHPS AS NOVEL ALKYLATING AGENTS | SHPRH, OGFR, COG3 | SLC1A1 459/4885GRM8 107/4885GRM6 23/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.